¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phase II block"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • phase shift effect
    À§»óº¯À§È¿°ú
  • phase transition
    À§»óÀüÀÌ
  • phase wraparound artifact
    À§»óµÑ·¯°ãħÀΰø¹°
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • plateau phase
    Á¤Á¡Áö¼Ó±â, ÆíÆò±â
  • positive phase
    1. ¾ç¼º»ó 2. Ç×üÁõ°¡±â
  • pachytene phase
    ±½Àº¼¶À¯±â, ÈÄ»ç±â
  • prodromal phase
    Àü±¸±â
  • phase
    1. ±â 2. »ó, À§»ó
  • phase advance
    À§»óÀüÁø
  • phase artifact
    À§»óÀΰø¹°
  • phase axis
    ˤȗ̈
  • phase boundary force
    »ó°èÀü·Â
  • phase boundary potential
    »ó°èÀüÀ§
  • phase coherence
    À§»ó°áÁý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • manic phase
    Á¶Áõ±â, µé¶ä±â
  • menstrual phase
    ¿ù°æ±â
  • mitosis phase
    À¯»çºÐ¿­±â
  • modulation phase
    º¯Á¶À§»ó
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • negative phase
    À½¼º±â, À½¼º»ó
  • orgasmic phase
    ±ØÄ¡±â
  • ovogenetic phase
    ³­Àڹ߻ý±â
  • phase
    »ó, ±â, À§»ó
  • pachytene phase
    ±½Àº¼¶À¯±â
  • phase ratio
    »óºñ
  • phase reversal
    À§»ó¹ÝÀü
  • phase rule
    »óÀǹýÄ¢, »ó±ÔÄ¢
  • phase shift
    À§»óº¯À§, À§»óÀ̵¿
  • phase splitter
    ºÐ»ó±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • phase frequency swap
    À§»ó Á֯ļö ±³È¯
  • phase image
    À§»ó ¿µ»ó
  • phase mismapping
    À§»ó ¿ÀÁöµµÀÛ¼º
  • phase of cornification
    °¢Áú±â
  • phase of decline
    °¨Åð±â, °¨¼Ò±â
  • phase of desquamation
    ¹Ú¸®±â
  • phase of incornification
    ºñ°¢Áú±â
  • phase of life problem
    ÀλýÁÖ±âÀÇ ¹®Á¦
  • phase of meditation
    Àẹ±â°£(íÖÜÑÑ¢Êà).
  • phase of rapid filling
    ±Þ¼ÓÃæ¸¸±â(ÐááÜ õöØ»Ðï).
  • phase of relaxation
    À̿ϱâ(ì¬èÐÐï).
  • phase of shortening
    ´ÜÃà±â(Ó­õêÑ¢).
  • phase offset multiplannar (POMP) imaging
    À§»ó ¿ÀÇÁ¼Â ´Ù¸é ¿µ»ó
  • phase plate
    À§»óÆÇ(êÈßÓ÷ù).
  • phase ratio
    »óºñ(ßÓÝï).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • intraventricular block
    ½É½Ç³»Â÷´Ü.
  • laryngeal nerve block
    ÈĵνŰæÂ÷´Ü.
  • lateral femoral cutaneous nerve block
    ¿ÜÃø´ëÅðÇǽŰæÂ÷´Ü(èâö°ÓÞ!!ù«ãêÌè ó´Ó¨).
  • left bundle branch block
    Á°¢Â÷´Ü.
  • lower incisor nerve block
    ÇϹ®Ä¡<ÀýÄ¡>½Å°æÂ÷´Ü(ù»Ú¦öÍ<ôîöÍ>ãêÌèó´?
  • lumbar sympathetic block
    ¿äºÎ±³°¨½Å°æÂ÷´Ü
  • mandibular nerve block
    ÇϾǽŰæÂ÷´Ü
  • mandibular nerve block
    ÇϾǽŰæÂ÷´Ü(ù»äÉãêÌèó´Ó¨).
  • maxillary nerve block
    »ó¾Ç½Å°æÂ÷´Ü
  • maxillary nerve block
    »ó¾Ç½Å°æÂ÷´Ü(ß¾äÉãê Ìèó´Ó¨).
  • median nerve block
    Á¤Á߽ŰæÂ÷´Ü.
  • mental block
    ÀǽÄÂ÷´Ü(ëòãÛó´Ó¨).
  • mental nerve block
    ÅνŰæÂ÷´Ü.
  • metallic block calorimeter
    ±Ý¼Ó¿­·®°è(Ë»ËÛËçËâË­).
  • nasopalatine block
    ÀýÄ¡°ñ½Å°æÂ÷´Ü.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
PCB paracervical block; polychlorinated biphenyl; portacaval bypass; postcoital bleeding; procarbazine
PNB p-nitrobiphenyl; perineal needle biopsy; peripheral nerve block; premature nodal beat
PVB cis-platinum, vinblastine, bleomycin; paravertebral block; premature ventricular beat
RBBB right bundle-branch block
RBBsB right bundle-branch system block
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
LPR Late phase response
LPD Luteal phase defect
LPD Luteal phase deficiency
MPF M phase promoting factor
MSPD Matrix Solid-Phase Dispersion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • posterior superior alveolar nerve block
    ÈÄ»ó Ä¡Á¶ ½Å°æ ¸¶Ãë
  • rate dependent bundle branch block
    ½É¹Ú ¼ö ÀÇÁ¸¼º °¢ Â÷´Ü
  • recent sympathetic block
    ±Ù ±³°¨½Å°æ Â÷´Ü
  • right bundle branch block
    ¿ì°¢ ºí·Ï, ¿ì°¢ Â÷´Ü
  • sacral block
    õ°ñ Â÷´Ü, õ°ñ ¸¶Ãë
  • saddle block
    ¾ÈÀå Â÷´Ü, »õµé ¸¶Ãë, »õµé ¸¶Ãë¹ý
    ¸¶Ãë¾×ÀÇ »ó½ÂÀ» ¸·±â À§ÇØ, Æ÷µµ´ç¾×À» °¡ÇØ ºñÁßÀ» Å©°Ô ÇÑ ´©Æä¸£Ä«ÀÎÀ» ¿äÃß ¸¶ÃëÀÇ ¿ä·ÉÀ¸·Î Áö¸Á¸· Çϰ­¿¡ ÁÖÀÔÇÏ¿© S¥²,¥³ ¿µ¿ª¿¡¸¸ ¸¶Ã븦 ±¹ÇÑÇÏ´Â ¹ýÀ¸·Î, ÁÖ·Î ¹«Åë ºÐ¸¸¿¡ ÀÌ¿ëµÈ´Ù.
  • splanchnic nerve block
    ³»Àå ½Å°æ Â÷´Ü
  • stellate ganglion block
    À§¼º ½Å°æÀý Â÷´Ü, ¼º»ó ½Å°æÀý Â÷´Ü
  • subarachnoid absolute alcohol block
    ÁöÁÖ¸·ÇÏ ¼ø ¾ËÄÝ Â÷´Ü
  • subarachnoid block
    ÁöÁÖ¸·ÇÏ Â÷´Ü, °Å¹Ì¸·ÇÏ Â÷´Ü
  • subarachnoid neurolytic block
    °Å¹Ì¸·ÇÏ ½Å°æÆÄ±«Á¦ Â÷´Ü
  • subdural block
    °æ¸·ÇÏ Â÷´Ü, °æ¸·³» Â÷´Ü
  • sun block lotion
    ÅÂ¾ç ±¤¼± Â÷´Ü Å©¸²
  • suprascapular nerve block
    °ß°©»ó ½Å°æ Â÷´Ü
  • sympathetic block
    ±³°¨½Å°æ Â÷´Ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
clinical trials, phase I Studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the u.s. And in other countries.
(12 Dec 1998)
clinical trials, phase II Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the u.s. And in other countries.
(12 Dec 1998)
clinical trials, phase III Comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the u.s. And in other countries.
(12 Dec 1998)
clinical trials, phase IV Planned post-marketing studies of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques that have been approved for general sale. These studies are often conducted to obtain additional data about the safety and efficacy of a product. This concept includes phase IV studies conducted in both the u.s. And in other countries.
(12 Dec 1998)
M phase Mitotic phase of cell cycle of eukaryotic cells, as distinct from the remainder, which is known as interphase (and that can be further subdivided as G1, s and G2). Beginning of M is signalled by separation of centrioles, where present and by the condensation of chromatin into chromosomes. M phase ends with the establishment of nuclear membranes around the two daughter nuclei, normally followed immediately by cell division (cytokinesis).
(18 Nov 1997)
M phase promoting factor Protein whose levels rise rapidly just before and fall away just after, mitosis. Thought to be a trigger for mitosis.
(18 Nov 1997)
plateau phase <oncology> Stable stage of disease in multiple myeloma following good response to anti-cancer treatment.
(31 Dec 1997)
continuous phase The medium or fluid in which a disperse is suspended.
Synonym: continuous phase, dispersion medium, dispersion phase, external medium.
(05 Mar 2000)
coupling phase The physical relationship of two syntenic genes. If they are on the same chromosome, they are said to be "in coupling" or "in the cis phase"; if on opposite members of a chromosome pair, "in repulsion" or "in the trans phase."
(05 Mar 2000)
positive phase The period following the negative phase, during which the opsonic index rises.
(05 Mar 2000)
postimplantation phase The time period between implantation and placentation.
(12 Dec 1998)
postmeiotic phase The stage following that of reduction of the chromosomes in the sexual cells, representing the mature forms of these cells, ending with the conjugation of the nuclei in the impregnated ovum.
Synonym: postreduction phase.
(05 Mar 2000)
postmitotic phase The period of the cell cycle after cell division when there is synthesis of RNA and protein; it may last for a few hours in rapidly growing tissue or a lifetime in non-renewing cells such as nerve cells.
Synonym: Gap1 phase, postmitotic phase.
(05 Mar 2000)
postreduction phase The stage following that of reduction of the chromosomes in the sexual cells, representing the mature forms of these cells, ending with the conjugation of the nuclei in the impregnated ovum.
Synonym: postreduction phase.
(05 Mar 2000)
poststationary phase The period in the growth of a bacterial culture in which growth is declining.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á